We're building value and opportunity by investing in cybersecurity, analytics, digital solutions, engineering and science, and consulting. Our culture of innovation empowers employees as creative thinkers, bringing unparalleled value for our clients and for any problem we try to tackle.
Booz Allen Commercial delivers advanced cyber defenses to the Fortune 500 and Global 2000. We are technical practitioners and cyber-focused management consultants with unparalleled experience – we know how cyber-attacks happen and how to defend against them.
Our strategy and technology consultants have empowered our international clients with the knowledge and experience they need to build their own local resources and capabilities.
In facing challenges of modernization, our Middle East and North Africa clients have complex requirements that benefit from our proven experience in guiding major programs and projects for governments and private-sector organizations. The services we offer in UAE, Qatar, Egypt, Turkey, Kuwait, Morocco, Jordan, and other regional countries build on our consulting legacy.
Our clients call upon us to work on their hardest problems—delivering effective health care, protecting warfighters and their families, keeping our national infrastructure secure, bringing into focus the traditional boundaries between consumer products and manufacturing as those boundaries blur.
Booz Allen was founded on the notion that we could help companies succeed by bringing them expert, candid advice and an outside perspective on their business. The analysis and perspective generated by that talent can be found in the case studies and thought leadership produced by our people.
Explore our featured teams and missions. Search openings and find out how you can support our meaningful missions.
Continue your mission with us. Get advice from our recruiting team, and browse our FAQs.
Seeking an internship or entry-level position? Learn about the impact you can make on our team.
Find out more about our application process, explore our benefits, and review our FAQs.
Learn more about Booz Allen's diverse culture and environment of inclusion that fosters respect and opportunity for all employees.
Our 22,600 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
Booz Allen takes pride in a culture that encourages and rewards the many dimensions of leadership—innovative thinking, active collaboration, and personal service. We’re particularly proud of the diversity of our Leadership Team and Board of Directors, among the most diverse in corporate America today.
October 29, 2014
BOSTON-BASED COMPANY PROVIDES EPIDEMIOLOGICAL AND ANALYTIC EXPERTISE TO FEDERAL, COMMERCIAL AND INTERNATIONAL CLIENTS
McLean, VA — Booz Allen Hamilton today announced that it has acquired Boston, MA.-based Epidemico, Inc., a move that underscores the firm’s commitment to further develop leading edge analytic capabilities in critical areas such as population health.
Epidemico is an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health, including disease outbreaks, drug safety, supply chain vulnerabilities and more. By combining innovative data acquisition and analysis technologies with public health expertise, Epidemico delivers sophisticated surveillance systems and consumer-centric engagement tools.
“The acquisition of Epidemico aligns closely with our Vision 2020 long-term growth strategy, expanding our client offerings with some truly leading capabilities and products that will drive growth opportunities,” said Booz Allen President and Chief Operating Officer Horacio Rozanski. “The addition of Epidemico’s analytic capabilities to our data science team builds on the firm’s broader strategy of expanding its engineering and technology expertise to respond to the changing demands of government and commercial clients seeking more cost-effective and innovative solutions.”
Epidemico, with a staff of industry recognized epidemiologists and health leaders, is known for pioneering global population health solutions that radically disrupt traditional detection, reporting and engagement systems. For example, one of Epidemico’s commercially licensed products, HealthMap, leads the field in digital disease detection tracking over 200 infectious diseases worldwide in 15 different languages.
Epidemico’s suite of cloud-based solutions serve as trusted resources for the public, government officials, life science, financial and Fortune 500 companies both in the U.S. and internationally. Several products are also directly supported by government entities such as the Food and Drug Administration, Centers for Disease Control and Department of Homeland Security. The company’s work has been nationally recognized by the Smithsonian Institution and the Library of Congress as well as media, including the New York Times, NBC and CNN.
The team at Epidemico, which is a commercial spinoff of Boston Children’s Hospital, Harvard Medical School and the Massachusetts Institute of Technology, has a deep understanding of how to extract value from multiple large data sets and a proven ability to translate that expertise into a rapidly growing business. Likewise, the proprietary software platform is transferrable to multiple industries and business use cases. The combination of Epidemico with Booz Allen’s world class data science capability, and federal and commercial health teams enhances the firm’s collective ability to support a broad set of client needs.
“Being part of Booz Allen Hamilton is very exciting for us,” said Epidemico President and Chief Operating Officer Robin Heffernan. “The teaming works on many levels – overlapping expertise, synergistic product/service mix, and a shared collaborative spirit. This combination will accelerate the development of comprehensive, integrated solutions that will enhance value to clients in both the short and longer-term.”
“This acquisition is perfectly aligned to Booz Allen’s Innovation agenda, adding a creative and successful start-up to our firm,” said Executive Vice President Karen Dahut, who leads the firm’s Strategic Innovation Group. “Their set of successful products, with several popular social media feeds, will also accelerate our efforts to develop alternative revenue streams for Booz Allen.”
Executive Vice President Fred Blackburn, who oversees Booz Allen’s NextGen Analytics Initiative, noted how this acquisition fits “as a critical first step in our broader strategy of growth through organic and inorganic investment – building a full portfolio of analytic platforms and solutions to address the critical need for improved analytics and data science across our client base. We believe that the Health analytics space is the ideal place to begin executing that strategy, given its obvious importance to the population, as well as the associated business opportunities.”
Information about Epidemico is available at http://epidemico.com/
About Booz Allen
For more than 100 years, business, government, and military leaders have turned to Booz Allen Hamilton to solve their most complex problems. They trust us to bring together the right minds: those who devote themselves to the challenge at hand, who speak with relentless candor, and who act with courage and character. They expect original solutions where there are no roadmaps. They rely on us because they know that—together—we will find the answers and change the world.
We solve the most difficult management and technology problems through a combination of consulting, analytics, digital solutions, engineering, and cyber expertise. With global headquarters in McLean, Virginia, our firm employs approximately 24,600 people globally, and had revenue of $6.17 billion for the 12 months ended March 31, 2018. To learn more, visit www.boozallen.com. (NYSE: BAH)